Matches in SemOpenAlex for { <https://semopenalex.org/work/W2808897013> ?p ?o ?g. }
- W2808897013 endingPage "920" @default.
- W2808897013 startingPage "907" @default.
- W2808897013 abstract "Objective Since 2010, several non–vitamin K antagonist oral anticoagulants (NOACs) have been brought to the U.S. market, yet little is known regarding their evolving adoption for prophylaxis of atrial fibrillation (AF)-related stroke. We examined temporal trends in choice of oral anticoagulants (OACs) among incident OAC users with AF and its association with patient demographic and clinical characteristics. Methods We conducted a serial cross-sectional analysis of medical and pharmacy claims for commercial and Medicare Advantage enrollees in a large, private, U.S. health plan. We identified 112,187 adults with nonvalvular AF starting OACs between October 2010 and March 2017. Multivariable logistic regression was used to examine the associations of patient characteristics with prescription of NOACs versus warfarin. Multinomial logistic regression was used to test the associations of patient characteristics with choice among NOACs. Results The prescription of NOACs has increased dramatically since their introduction in October 2010. In the first quarter of 2017 (2017Q1), 7502 patients started OACs, of whom 78.9% used NOACs and 21.1% warfarin. For NOACs, 3.8% used dabigatran, 25.0% rivaroxaban, and 50.1% apixaban. In multivariable analyses, factors associated with choice of NOACs versus warfarin included younger age, lower stroke or bleeding risk, fewer comorbidities, higher education level or household net worth, and prescription by cardiologists (all p<0.001). There was no sex difference in likelihood of filling NOACs versus warfarin in 2010Q4–2012, but women had higher odds of starting NOACs (odds ratio = 1.19; 95% confidence interval = 1.14–1.25) in 2015–2017Q1. Among NOAC users, the odds of apixaban prescription increased with age, female sex, stroke or bleeding risk, and comorbidities (all p<0.05). Conclusion NOAC prescriptions have increased substantially among incident OAC users with nonvalvular AF, predominantly driven by increased prescription of apixaban. Warfarin and apixaban were generally preferred for elderly patients, patients with higher stroke or bleeding risk, and patients with more comorbidities." @default.
- W2808897013 created "2018-06-29" @default.
- W2808897013 creator A5004320483 @default.
- W2808897013 creator A5005567441 @default.
- W2808897013 creator A5010621055 @default.
- W2808897013 creator A5025840041 @default.
- W2808897013 creator A5075752624 @default.
- W2808897013 date "2018-07-26" @default.
- W2808897013 modified "2023-10-01" @default.
- W2808897013 title "Trends and Variation in Oral Anticoagulant Choice in Patients with Atrial Fibrillation, 2010-2017" @default.
- W2808897013 cites W1490007665 @default.
- W2808897013 cites W1539721984 @default.
- W2808897013 cites W1561288333 @default.
- W2808897013 cites W1641613989 @default.
- W2808897013 cites W1902416941 @default.
- W2808897013 cites W1944375371 @default.
- W2808897013 cites W1975650244 @default.
- W2808897013 cites W1982056303 @default.
- W2808897013 cites W1999047261 @default.
- W2808897013 cites W2023819634 @default.
- W2808897013 cites W2032692730 @default.
- W2808897013 cites W2057250169 @default.
- W2808897013 cites W2058611793 @default.
- W2808897013 cites W2061326496 @default.
- W2808897013 cites W2067443499 @default.
- W2808897013 cites W2069773373 @default.
- W2808897013 cites W2088144189 @default.
- W2808897013 cites W2089534375 @default.
- W2808897013 cites W2096246254 @default.
- W2808897013 cites W2097854437 @default.
- W2808897013 cites W2106828417 @default.
- W2808897013 cites W2110571427 @default.
- W2808897013 cites W2111947972 @default.
- W2808897013 cites W2121394112 @default.
- W2808897013 cites W2127985968 @default.
- W2808897013 cites W2136489990 @default.
- W2808897013 cites W2157711058 @default.
- W2808897013 cites W2161876144 @default.
- W2808897013 cites W2162508946 @default.
- W2808897013 cites W2167698566 @default.
- W2808897013 cites W2174392985 @default.
- W2808897013 cites W2276319526 @default.
- W2808897013 cites W2341244029 @default.
- W2808897013 cites W2433454023 @default.
- W2808897013 cites W2509795914 @default.
- W2808897013 cites W2510777240 @default.
- W2808897013 cites W2523933248 @default.
- W2808897013 cites W2538943279 @default.
- W2808897013 cites W2604378539 @default.
- W2808897013 cites W2611798950 @default.
- W2808897013 cites W2613413186 @default.
- W2808897013 cites W2625703504 @default.
- W2808897013 cites W2724699208 @default.
- W2808897013 cites W2736709829 @default.
- W2808897013 cites W2736956220 @default.
- W2808897013 cites W2765710269 @default.
- W2808897013 cites W2766383072 @default.
- W2808897013 cites W2781162030 @default.
- W2808897013 cites W2915181639 @default.
- W2808897013 cites W4205645630 @default.
- W2808897013 doi "https://doi.org/10.1002/phar.2158" @default.
- W2808897013 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6448138" @default.
- W2808897013 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29920705" @default.
- W2808897013 hasPublicationYear "2018" @default.
- W2808897013 type Work @default.
- W2808897013 sameAs 2808897013 @default.
- W2808897013 citedByCount "142" @default.
- W2808897013 countsByYear W28088970132018 @default.
- W2808897013 countsByYear W28088970132019 @default.
- W2808897013 countsByYear W28088970132020 @default.
- W2808897013 countsByYear W28088970132021 @default.
- W2808897013 countsByYear W28088970132022 @default.
- W2808897013 countsByYear W28088970132023 @default.
- W2808897013 crossrefType "journal-article" @default.
- W2808897013 hasAuthorship W2808897013A5004320483 @default.
- W2808897013 hasAuthorship W2808897013A5005567441 @default.
- W2808897013 hasAuthorship W2808897013A5010621055 @default.
- W2808897013 hasAuthorship W2808897013A5025840041 @default.
- W2808897013 hasAuthorship W2808897013A5075752624 @default.
- W2808897013 hasBestOaLocation W28088970131 @default.
- W2808897013 hasConcept C126322002 @default.
- W2808897013 hasConcept C127413603 @default.
- W2808897013 hasConcept C151956035 @default.
- W2808897013 hasConcept C156957248 @default.
- W2808897013 hasConcept C2426938 @default.
- W2808897013 hasConcept C2776291444 @default.
- W2808897013 hasConcept C2776301958 @default.
- W2808897013 hasConcept C2776704044 @default.
- W2808897013 hasConcept C2778661090 @default.
- W2808897013 hasConcept C2778810321 @default.
- W2808897013 hasConcept C2778858636 @default.
- W2808897013 hasConcept C2779161974 @default.
- W2808897013 hasConcept C2780290652 @default.
- W2808897013 hasConcept C2780638905 @default.
- W2808897013 hasConcept C2780645631 @default.
- W2808897013 hasConcept C44249647 @default.
- W2808897013 hasConcept C71924100 @default.
- W2808897013 hasConcept C78519656 @default.